TerrAscend (TSNDF) Total Liabilities (2021 - 2026)
TerrAscend's (TSNDF) quarterly Total Liabilities came in at $458.2 million in Q1 2026, up 5.17% year-on-year from $435.6 million in Q1 2025, and little changed on a QoQ basis from $458.4 million in Q4 2025.
TerrAscend (TSNDF) Total Liabilities (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Total Liabilities data on file, last reported at $458.2 million in Q1 2026.
- On a quarterly basis, Total Liabilities rose 5.17% year-over-year to $458.2 million in Q1 2026; TTM through Mar 2026 was $458.2 million, a 5.17% increase from a year earlier, with the FY2025 full-year figure at $458.4 million, up 6.49% from the prior year.
- Total Liabilities for Q1 2026 stood at $458.2 million, roughly flat from $458.4 million in the prior quarter.
- Over the last five years, Total Liabilities for TSNDF reached as high as $511.2 million in Q1 2022 and fell as low as $380.4 million in Q4 2022.
- Historically, Total Liabilities has averaged $441.7 million across 5 years, with a median of $446.7 million in 2022.
- On a YoY basis, Total Liabilities climbed as much as 11.92% in 2023 and fell as far as 21.3% in 2023.
- Year by year, Total Liabilities stood at $380.4 million in 2022, then increased by 11.92% to $425.8 million in 2023, then advanced by 1.09% to $430.4 million in 2024, then rose by 6.49% to $458.4 million in 2025, then slipped by 0.04% to $458.2 million in 2026.
- Per Business Quant data, the three most recent Total Liabilities figures were $458.2 million in Q1 2026, $458.4 million in Q4 2025, and $459.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 458.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 458.16 Mn |
| Dec 31, 2025 | 458.36 Mn |
| Sep 30, 2025 | 459.78 Mn |
| Jun 30, 2025 | 453.62 Mn |
| Mar 31, 2025 | 435.63 Mn |
| Dec 31, 2024 | 430.42 Mn |
| Sep 30, 2024 | 449.81 Mn |
| Jun 30, 2024 | 434.10 Mn |
| Mar 31, 2024 | 423.43 Mn |
| Dec 31, 2023 | 425.78 Mn |
| Sep 30, 2023 | 449.88 Mn |
| Jun 30, 2023 | 426.15 Mn |
| Mar 31, 2023 | 402.28 Mn |
| Dec 31, 2022 | 380.42 Mn |
| Sep 30, 2022 | 446.67 Mn |
| Jun 30, 2022 | 463.65 Mn |
| Mar 31, 2022 | 511.16 Mn |
| Dec 31, 2021 | 352.98 Mn |